Equity Incentive Plan (Details) - USD ($) $ / shares in Units, $ in Millions |
1 Months Ended | 3 Months Ended | 9 Months Ended | ||||||
|---|---|---|---|---|---|---|---|---|---|
Jan. 01, 2021 |
Mar. 31, 2021 |
Sep. 30, 2022 |
Jun. 30, 2022 |
Mar. 31, 2022 |
Sep. 30, 2021 |
Jun. 30, 2021 |
Sep. 30, 2022 |
Sep. 30, 2021 |
|
| Equity Incentive Plan (Details) [Line Items] | |||||||||
| Fair value of stock option (in Dollars per share) | $ 1.23 | $ 1.61 | |||||||
| Stock options exercised (in Shares) | 51,602 | ||||||||
| Intrinsic value options exercised | $ 0.1 | ||||||||
| Intrinsic value options outstanding | $ 2.6 | 2.6 | |||||||
| Intrinsic value options exercisable | $ 2.4 | 2.4 | |||||||
| Share-based compensation | $ 3.1 | ||||||||
| Weighted average requisite service period | 2 years 7 months 6 days | ||||||||
| Stock based compensation for stock options, description | the Company granted 727,922 stock options to the Chief Executive Officer (“CEO”) under the 2020 Plan with an exercise price of $3.00 per share. The options vest based on the CEO’s continued service in addition to the following terms: ● 317,688 options vest in full when the closing price of the Company’s common stock reaches or exceeds $9.00 per share for 20 out of 30 trading days after the Company becomes listed on the New York Stock Exchange or Nasdaq. These options expire on March 3, 2031. ● 46,273 options vest in full when the closing price of the Company’s common stock reaches or exceeds $9.00 per share for 20 out of 30 trading days after the Company becomes listed on the New York Stock Exchange or Nasdaq. Since the listing on Nasdaq, these options expire on March 22, 2031, instead of 2026. ● 363,961 options vest in full when the closing price of the Company’s common stock reaches or exceeds $13.50 per share for 20 out of 30 trading days after the Company becomes listed on the New York Stock Exchange or Nasdaq. Since the listing on Nasdaq, these options expire on March 22, 2031, instead of 2026. | ||||||||
| Share based compensation fair value, description | The Company’s assumptions for expected volatility, closing price and risk-free rate were 50.0%, $3.00 and 0.77%, respectively. The aggregate estimated fair value of the options was $0.4 million. The Company recognized $30,000 and $0.1 million in share-based expense for the three and nine months ended September 30, 2022, respectively. The Company recognized $22,000 and $38,000 in share-based expense for the three and nine months ended September 30, 2021, respectively. As of September 30, 2022, there was $0.2 million of unrecognized compensation costs which the Company plans to recognize over a weighted average period of 1.6 years. | ||||||||
| Common Stock [Member] | |||||||||
| Equity Incentive Plan (Details) [Line Items] | |||||||||
| Shares issued (in Shares) | 656,579 | 656,579 | |||||||
| Stock options exercised (in Shares) | 7,871 | 12,846 | 24,015 | 23,351 | 126,876 | ||||
| 2020 Equity incentive Plan [Member] | |||||||||
| Equity Incentive Plan (Details) [Line Items] | |||||||||
| Options contractual life | 10 years | ||||||||
| Number of shares equal percentage | 5.00% | ||||||||